Activated T lymphocytes resist the toxic effects of the adenosine deaminase inhibitor, 2-deoxycoformycin
- 1 September 1982
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 72 (1) , 64-76
- https://doi.org/10.1016/0008-8749(82)90283-0
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouseCellular Immunology, 1981
- Studies on the Biochemical Sequelae of Therapy in Thy-Acute Lymphoblastic Leukaemia with the Adenosine Deaminase Inhibitor 2’DeoxycoformycinBritish Journal of Haematology, 1981
- Capping and adenosine metabolism. Genetic and pharmacologic studies.The Journal of Experimental Medicine, 1980
- Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency diseaseCell, 1978
- Combined immunodeficiency disease associated with adenosine deaminase deficiency: Report on a Workshop Held in Albany, New York, October 1, 1973The Journal of Pediatrics, 1975
- Studies on a gross-virus-induced lymphoma in the rat. I. The cell-mediated immune responseInternational Journal of Cancer, 1974
- Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiencyThe Journal of Pediatrics, 1974
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973
- ADENOSINE-DEAMINASE DEFICIENCY AND COMBINED IMMUNODEFICIENCY SYNDROMEThe Lancet, 1972
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972